HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Stroke prevention].

Abstract
Life style modification has been shown to reduce stroke risk. In patients with risk factors several drugs have proven their efficacy. The most effective medications are antihypertensives, antidiabetics, statins and antithrombotics. In the prevention of recurrent stroke in patients with a noncardioembolic ischemic stroke antiplatelet agents are used. Aspirin or a combination aspirin/dipyridamol are the first-line agents. Clopidogrel is recommended for patients with aspirin intolerance, several risk factors or recurrent cerebrovascular events. Warfarin has demonstrated efficacy in stroke prevention in patients with cardioembolic stroke, cerebral venous thrombosis and antiphospholipid antibody syndrome. Other, less well established indications for warfarin in the secondary prevention of stroke are: symptomatic intracranial artery stenosis; large aortic atheroma and extracranial carotid or vertebral artery dissection.
AuthorsM Arnold, K Nedeltchev, Ph Lyrer, R W Baumgartner
JournalTherapeutische Umschau. Revue therapeutique (Ther Umsch) Vol. 60 Issue 9 Pg. 521-6 (Sep 2003) ISSN: 0040-5930 [Print] Switzerland
Vernacular TitleSchlaganfallprävention.
PMID14579620 (Publication Type: Comparative Study, English Abstract, Journal Article, Review)
Chemical References
  • Anticoagulants
  • Antihypertensive Agents
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin
Topics
  • Administration, Oral
  • Aged
  • Anticoagulants (administration & dosage, therapeutic use)
  • Antihypertensive Agents (therapeutic use)
  • Aspirin (therapeutic use)
  • Carotid Stenosis (complications, surgery)
  • Controlled Clinical Trials as Topic
  • Endarterectomy, Carotid
  • Fibrinolytic Agents (therapeutic use)
  • Humans
  • Hyperhomocysteinemia (complications, drug therapy)
  • Hyperlipidemias (complications, drug therapy)
  • Hypertension (complications, drug therapy)
  • Life Style
  • Meta-Analysis as Topic
  • Middle Aged
  • Nutritional Physiological Phenomena
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Prospective Studies
  • Risk Factors
  • Stroke (etiology, prevention & control)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: